Key Record Dates
| ClinicalTrials.gov Identifier: | NCT00389675 |
|---|---|
| Brief Title: | DORADO-AC-EX - A Long-Term Safety Extension Study to the Phase 3 DORADOC-AC Study (Protocol DAR-312) of Darusentan in Resistant Hypertension (Darusentan) |
| First Submitted : | October 17, 2006 |
| First Submitted that Met QC Criteria : | October 18, 2006 |
| First Posted : | October 19, 2006 (Estimate) |
| Certification/Extension First Submitted : | January 3, 2014 |
| Certification/Extension First Submitted that Met QC Criteria : | January 3, 2014 |
| Certification/Extension First Posted : | January 6, 2014 (Estimate) |
| Last Update Submitted that Met QC Criteria : | January 3, 2014 |
| Last Update Posted : | January 6, 2014 (Estimate) |